CUV News: CLINUVEL progresses vitiligo treatment program - 10th May 2022, 11:33am

annb0t

Top 20
Clinuvel Pharmaceuticals Limited

Novel approach to addressing pigment loss disorder affecting an estimated 45 million individuals worldwide

Vitiligo repigmentation in CLINUVEL's CUV102 study Initial clinical studies of afamelanotide showed the drug could repigment skin. This patient received four afamelanotide implants and NB-UVB light therapy over six months, largely repigmenting lesions on their eyelids. Images taken at days 0 and 171 of CUV102 study, courtesy of the study investigator.

MEL...

>>> Read more: CLINUVEL progresses vitiligo treatment program
 
Top Bottom